Coronary disease & ACS

Fractional flow reserve or 3D-quantitative-coronary-angiography based vessel-FFR guided revascularization. Rationale and study design of the prospective randomized fast III trial

Am Heart JPublished Rationale and design of a randomised controlled trial

Study context

Population
Patients with intermediate coronary lesions (30%-80% stenosis by visual assessment or QCA)planned approx
Planned comparison
Vessel fractional flow reserve (vFFR)-guided vs fractional flow reserve (FFR)-guided coronary revascularization
Primary endpoint
Composite of:
  • All-cause death
  • Any MI
  • Any revascularization
Follow-up
1-year post-randomization
Methodological detailsinvestigator-initiated, open label, multicenter, non-inferiority, Secondary end points: individual components of primary end point; cost-effectiveness
  • Investigator-initiated
  • Open label
  • Multicenter
  • Non-inferiority
  • Secondary end points: individual components of primary end point; cost-effectiveness

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

Fractional flow reserve or 3D-quantitative-coronary-angiography based vessel-FFR guided revascularization. Rationale and study design of the prospective randomized fast III trial. Am Heart J. Published 14 February 2023. doi:10.1016/j.ahj.2023.02.003

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.